Study: Bone-building drug blocks effects of steroids

04/12/2009 | Yahoo!

A Novartis-funded study found that a once-yearly injection of bone-building treatment Reclast was more effective than a daily dose of the oral bisphosphonate pill Actonel in reversing bone loss in patients who are taking glucocorticoid drugs to treat immune-related conditions, such as asthma and lupus. The study's lead author said he is optimistic that Reclast would get FDA approval to treat patients taking steroids.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MEDICAL SCIENCE LIAISON - 14000002RO
Abbott
Columbus, OH
Executive Medical Director
Aspirus Network Inc
Wausau, WI
Medical Director - Cataract
Abbott
Santa Ana, CA
Director, Membership
The Food and Drug Law Institute
Washington, DC
Manager, Compliance
Stryker
Fremont, CA